My ePortfolio Register   

Abstract | Full Editorial

Biomarkers, screening and prevention in cancer

Guest Editor: Jack Cuzick

This special issue explores the underdeveloped field of cancer prevention using pharmaceutical agents.  The seven original papers included in the issue focus on current barriers to acceptance of this approach and how they might be overcome.

Read full editorial

Watch Guest Editor Prof Jack Cuzick discuss the various articles in the special issue.

Special Issue articles

Special Issue: New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.601

Special Issue: Biomarkers of cancer angioprevention for clinical studies

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.600

Special Issue: Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.599

Special Issue: Molecular profile of liquid biopsies: next generation biomarkers to improve lung cancer treatment

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.598

Special Issue: Chemoprevention studies within lung cancer screening programmes

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.597

Special Issue: Risk factors and biomarkers of life-threatening cancers

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.596

Special Issue: Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake

Abstract | Full Article | PDF Published: 24 Nov 2015 / https://doi.org/10.3332/ecancer.2015.595



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence